Sp427

GUT MICROBIOME AS A DETERMINANT OF TREATMENT RESPONSE IN IBD

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

In this session, you will learn about the advances in microbial biotransformation of drugs and this can impact clinical outcomes and adverse events.

Presenter


Tracks

Related Products

Thumbnail for PLACEHOLDER
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Thumbnail for THE ROLE OF THE GUT MICROBIOME IN THE ASSOCIATION BETWEEN CITRUS FRUIT AND THE RISK OF DEPRESSION
THE ROLE OF THE GUT MICROBIOME IN THE ASSOCIATION BETWEEN CITRUS FRUIT AND THE RISK OF DEPRESSION
BACKGROUND: Diet is known to alter the risk of depression. Increasing data also demonstrate a causal role of the gut microbiome in mental illness, via the gut-brain axis. However, it remains unclear how diet and the microbiome mechanistically influence depression risk in humans…
Thumbnail for AN EMPIRICAL DIETARY PATTERN ASSOCIATED WITH GUT MICROBIAL FEATURES IN RELATION TO COLORECTAL CANCER RISK
AN EMPIRICAL DIETARY PATTERN ASSOCIATED WITH GUT MICROBIAL FEATURES IN RELATION TO COLORECTAL CANCER RISK
BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
Thumbnail for INTRODUCTION
INTRODUCTION
SOCIETY: AGA